Castleview Partners, LLC Laboratory Corp Of America Holdings Transaction History

Castleview Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	SELL	$213.86 - $277.87 $909,332 - $1.18 Million	-4,252 Reduced 95.51%	200 $46,000
Q2 2022 Aug 16, 2022	BUY	$213.86 - $277.87 $916,817 - $1.19 Million	4,287 Added 2598.18%	4,452 $1.04 Million
Q1 2022 May 16, 2022	SELL	$259.82 - $298.18 $12.9 Million - $14.8 Million	-49,794 Reduced 99.67%	165 $43,000
Q4 2021 Feb 17, 2022	BUY	$271.6 - $314.21 $13.4 Million - $15.5 Million	49,411 Added 9016.61%	49,959 $15.7 Million
Q2 2021 Aug 17, 2021	BUY	$251.87 - $278.14 $138,024 - $152,420	548 New	548 $151,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.